CN1895441A - Medicament for treating mastopathy - Google Patents
Medicament for treating mastopathy Download PDFInfo
- Publication number
- CN1895441A CN1895441A CN 200610017982 CN200610017982A CN1895441A CN 1895441 A CN1895441 A CN 1895441A CN 200610017982 CN200610017982 CN 200610017982 CN 200610017982 A CN200610017982 A CN 200610017982A CN 1895441 A CN1895441 A CN 1895441A
- Authority
- CN
- China
- Prior art keywords
- medicament
- chinese medicine
- spaleston
- aminophylline
- hydrochlorothiazide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A medicine for treating mastosis, mastoplasia, breast cancer, etc is prepared from 6 Chinese-medicinal materials including dodder seed, prunella spike, arctium fruit, etc and 6 Western medicines including methyl testosterone, euphyllin, assival, etc.
Description
Technical field:
The invention belongs to medical technical field, relate to the mastotic medicament of a kind of treatment.
Background technology
Breast disease is a commonly encountered disease, comprising: cyclomastopathy, mastitis, breast carcinoma, tuberculosis of breast, galactocele, mastadenoma etc. bring very big misery to the women, Therapeutic Method commonly used, adopt anti-inflammatory analgesic or adopt hormonotherapy, though toxic and side effects is little, curative effect is lower, long 3-4 course of treatment course of treatment.
Summary of the invention
The inventor through a large amount of breast disease case observations, tests in being engaged in the breast disease clinical treatment for many years, and purpose is to develop the mastotic medicament of a kind of treatment, can shorten the course of treatment, improves curative effect, removes breast disease patient's the misery of feeling embarrassed to mention preferably.
The technical solution used in the present invention is the mastotic medicament of a kind of treatment of development, adopts following weight portion scope Chinese medicine and Western medicine, forms through processing and preparing.
Red sorrel flower 150-800, careless energetically 180-850, Semen Cuscutae 200-900, Spica Prunellae 150-650, the imperial 100-750 that invigorates blood circulation, Fructus Arctii 150-800 also has methyl testosterone 2-10, aminophylline 10-50, thyroxine 5-20, hydrochlorothiazide 2-8, stable 1-6, spaleston 50-250.
In order to improve curative effect, the inventor is through the multiple-case test, and the present invention can also adopt following weight portion scope Chinese medicine and Western medicine: red sorrel flower 250-600, careless energetically 300-700, Semen Cuscutae 350-800, Spica Prunellae 200-600, imperial 150-650 invigorates blood circulation, Fructus Arctii 150-550 also has methyl testosterone 3-8, aminophylline 20-40, thyroxine 8-15, hydrochlorothiazide 3-6, stable 2-5, spaleston 90-230.
In order further to improve curative effect, preferred through the inventor, the present invention can also adopt following weight portion Chinese medicine and Western medicine: red sorrel flower 350-650, careless energetically 400-550, Semen Cuscutae 450-650, Spica Prunellae 300-550, imperial 250-550 invigorates blood circulation, Fructus Arctii 200-500 also has methyl testosterone 4-7, aminophylline 25-30, thyroxine 10-13, hydrochlorothiazide 4-5, stable 3-4, spaleston 130-200.
In said medicine, wherein, Chinese medicine red sorrel flower acts on bitterly for locality another name (" conventional Chinese medicine name and another name handbook, People's Health Publisher, Beijing, October calendar year 2001) has spasmolytic town gynecological; Grass is called (referring to above-mentioned bibliography) for the locality and is had anti-inflammation, dispelling wind and removing obstruction in the collateral, blood circulation promoting and dispersing pathogen accumulation effect energetically; Semen Cuscutae has the effect of the estrogen of reduction, and three medicines are monarch drug; Spica Prunellae, the eliminating stagnation of relieving inflammation or internal heat, the scrofula that disappears tumor; The dragon of invigorating blood circulation is locality another name (referring to above-mentioned bibliography) expelling wind and removing dampness, the dissipating blood stasis analgesic therapy; Fructus Arctii, detoxifcation, the skin ulcer that disappears is swollen, and three medicines are ministerial drug; Wherein, the Western medicine methyl testosterone has the estrogen action of falling; Aminophylline, spasmolytic diuresis, relaxing smooth muscle; Thyroxine, detumescence, endocrine regulation; Hydrochlorothiazide, diuresis; Stable relieving spasm to stop pain; Spaleston, analgesia.The present invention adopts the monarch and his subjects' Chinese Medicine and Clavicular, the Chinese and western drugs combination, and the dialectical combination of specimen, collaborative executing controlled the analgesia detumescence, blood circulation promoting and blood stasis dispelling is changed the knot softening the hard mass, has produced unexpected result in clinical trial, shorten the course of treatment, and curative effect improves, and has removed vast breast disease women's misery preferably.
The mastotic medicament of this treatment of the present invention, through thousands of routine clinic trial, more obvious to the cyclomastopathy curative effect especially, cure rate is more than 90%, effective percentage 100% can obviously be lengthened the life more than 5 years to the patient with breast cancer, and other breast disease is also shown curative effect preferably.In clinical trial, finding has slight side effect, takes as long as abide by to advise, and toxic and side effects can overcome.
The specific embodiment:
Medicament of the present invention through the clinical for many years a large amount of case tests of inventor, is updated, and following examples prescription is all effective to the breast disease treatment.
Example formulations 1, adopt following weight portion Chinese medicine and Western medicine: red sorrel spends 150, grass 180 energetically, Semen Cuscutae 200, Spica Prunellae 150, the dragon 100 of invigorating blood circulation, Fructus Arctii 150, methyl testosterone 2, aminophylline 10, thyroxine 5, hydrochlorothiazide 2, stable 1, spaleston 50.Look over so as to check through pulverizing, mixed, by capsular conventional preparation method preparation.
Example formulations 2, adopt following weight portion Chinese medicine and Western medicine: red sorrel spends 800, energetically the grass 850, Semen Cuscutae 900, Spica Prunellae 650, invigorate blood circulation the dragon 750, Fructus Arctii 800, methyl testosterone 10, aminophylline 50, thyroxine 20, hydrochlorothiazide 8 stabilizes 6, spaleston 250.
Example formulations 3, adopt following weight portion Chinese medicine and Western medicine: red sorrel spends 250, grass 300 energetically, Semen Cuscutae 350, Spica Prunellae 200, the dragon 150 of invigorating blood circulation, Fructus Arctii 150, methyl testosterone 3, aminophylline 20, thyroxine 8, hydrochlorothiazide 3, stable 2, spaleston 90.
Example formulations 4, adopt following weight portion Chinese medicine and Western medicine: red sorrel spends 600, grass 700 energetically, Semen Cuscutae 800, Spica Prunellae 600, the dragon 650 of invigorating blood circulation, Fructus Arctii 550, methyl testosterone 8, aminophylline 40, thyroxine 15, hydrochlorothiazide 6, stable 5, spaleston 230.
Example formulations 5, adopt following weight portion Chinese medicine and Western medicine: red sorrel spends 350, grass 400 energetically, Semen Cuscutae 450, Spica Prunellae 300, the dragon 250 of invigorating blood circulation, Fructus Arctii 200, methyl testosterone 4, aminophylline 25, thyroxine 10, hydrochlorothiazide 4, stable 3, spaleston 130.
The instructions of taking of medicament of the present invention and points for attention:
Capsule is for oral administration, every day 3 times, each 2, cyclomastopathy patient 1-2 course of treatment, 40 is a course of treatment, in order to prevent toxic and side effects, abide by the doctor and take, should begin to take the 5th day that menstruation comes, serve on 20 days, but 1-2 course of treatment of other breast disease proper extension is aided with other method, also can obtain curative effect preferably.
Can further specify significant curative effect of the present invention from the summary model case.
Model case 1, Zhang Tian *, the woman, 48 years old now, Tianjin village people was closed in the Xincai County, Henan Province, and two lump in breasies are very big for many years during prescription on individual diagnosis, not recurrence so far after take medicament of the present invention, curing 1 course of treatment.
Model case 2, Song is good *, the woman, 46 years old now, Tianjin village people was closed in the Xincai County, Henan Province, cyclomastopathy, during prescription on individual diagnosis, once the multi-treatment poor effect is cured through taking medicament of the present invention 1 course of treatment.
Model case 3, Li Ming *, the woman, 36 years old now, shop, ten li of Xincai County, Henan Province village people, through many families diagnosis cyclomastopathy, curative effect does not show, and through taking 1 course of treatment of medicament of the present invention, cures and does not send out so far.
Model case 4, the woman, prunus mume (sieb.) sieb.et zucc. just *, 52 years old, Tianjin village people was closed in the Xincai County, suffered from breast cancer, and because of the unable operation of family financial situation difficulty, had faced during prescription on individual diagnosis and can not perform the operation late period, through taking medicament of the present invention after four courses of treatment, was clearly better, and is dead after 5 years.
Claims (8)
1, the mastotic medicament of a kind of treatment adopts following weight portion Chinese medicine and Western medicine, forms through processing and preparing, it is characterized in that Chinese medicine comprises red sorrel flower 150-800, careless energetically 180-850, Semen Cuscutae 200-900, Spica Prunellae 150-650, the imperial 100-750 that invigorates blood circulation, Fructus Arctii 150-800, also has Western medicine methyl testosterone 2-10, aminophylline 10-50, thyroxine 5-20, hydrochlorothiazide 2-8, stable 1-6, spaleston 50-250.
2, the mastotic medicament of treatment as claimed in claim 1 is characterized in that described Chinese medicine and Western medicine can adopt following weight portion: Chinese medicine red sorrel flower 250-600, careless energetically 300-700, Semen Cuscutae 350-800, Spica Prunellae 200-600, the imperial 150-650 that invigorates blood circulation, Fructus Arctii 150-550, also has Western medicine methyl testosterone 3-8, aminophylline 20-40, thyroxine 8-15, hydrochlorothiazide 3-6, stable 2-5, spaleston 90-230.
3, the mastotic medicament of treatment as claimed in claim 1 is characterized in that described Chinese medicine and Western medicine can adopt following weight portion: red sorrel flower 350-650, careless energetically 400-550, Semen Cuscutae 450-650, Spica Prunellae 300-550, the imperial 250-550 that invigorates blood circulation, Fructus Arctii 200-500, also has methyl testosterone 4-7, aminophylline 25-30, thyroxine 10-13, hydrochlorothiazide 4-5, stable 3-4, spaleston 130-200.
4, the mastotic medicament of treatment as claimed in claim 1, it is characterized in that described Chinese medicine and Western medicine can adopt following weight portion: red sorrel spends 150, energetically grass 180, Semen Cuscutae 200, Spica Prunellae 150, the dragon 100 of invigorating blood circulation, Fructus Arctii 150, methyl testosterone 2, aminophylline 10, thyroxine 5, hydrochlorothiazide 2, stabilize 1, spaleston 50.
5, the mastotic medicament of treatment as claimed in claim 1, it is characterized in that described Chinese medicine and Western medicine can adopt following weight portion: red sorrel spends 800, energetically grass 850, Semen Cuscutae 900, Spica Prunellae 650, the dragon 750 of invigorating blood circulation, Fructus Arctii 800, methyl testosterone 10, aminophylline 50, thyroxine 20, hydrochlorothiazide 8, stabilize 6, spaleston 250.
6, the mastotic medicament of treatment as claimed in claim 1 or 2, it is characterized in that described Chinese medicine and Western medicine can adopt following weight portion: red sorrel spends 250, energetically grass 300, Semen Cuscutae 350, Spica Prunellae 200, the dragon 150 of invigorating blood circulation, Fructus Arctii 150, methyl testosterone 3, aminophylline 20, thyroxine 8, hydrochlorothiazide 3, stabilize 2, spaleston 90.
7, the mastotic medicament of treatment as claimed in claim 1 or 2, it is characterized in that described Chinese medicine and Western medicine can adopt following weight portion: red sorrel spends 600, energetically grass 700, Semen Cuscutae 800, Spica Prunellae 600, the dragon 650 of invigorating blood circulation, Fructus Arctii 550, methyl testosterone 8, aminophylline 40, thyroxine 15, hydrochlorothiazide 6, stabilize 5, spaleston 230.
8, as claim 1 or the mastotic medicament of 2 or 3 described treatments, it is characterized in that described Chinese medicine and Western medicine can adopt following weight portion: red sorrel spends 350, energetically grass 400, Semen Cuscutae 450, Spica Prunellae 300, the dragon 250 of invigorating blood circulation, Fructus Arctii 200, methyl testosterone 4, aminophylline 25, thyroxine 10, hydrochlorothiazide 4, stabilize 3, spaleston 130.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100179820A CN100421696C (en) | 2006-06-12 | 2006-06-12 | Medicament for treating mastopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100179820A CN100421696C (en) | 2006-06-12 | 2006-06-12 | Medicament for treating mastopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1895441A true CN1895441A (en) | 2007-01-17 |
| CN100421696C CN100421696C (en) | 2008-10-01 |
Family
ID=37608181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100179820A Expired - Fee Related CN100421696C (en) | 2006-06-12 | 2006-06-12 | Medicament for treating mastopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100421696C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT5701B (en) | 2010-03-29 | 2010-12-27 | VšĮ "Grunto valymo technologijos" | Phytochemical composition, method of preparation and use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1186060C (en) * | 2002-10-17 | 2005-01-26 | 王长奎 | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method |
-
2006
- 2006-06-12 CN CNB2006100179820A patent/CN100421696C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT5701B (en) | 2010-03-29 | 2010-12-27 | VšĮ "Grunto valymo technologijos" | Phytochemical composition, method of preparation and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100421696C (en) | 2008-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101564474B (en) | Foot soaking preparation for treating gout and preparation method thereof | |
| CN101732521B (en) | Medicinal composition for treating fracture and preparation method thereof | |
| CN102743665B (en) | Chinese medicinal composition for promoting healing after boneblast, as well as preparation method and application thereof | |
| CN101926867B (en) | Bone fracture recovering soup | |
| CN1583112A (en) | Capsules for nourishing kidney and strengthening yang | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN100421696C (en) | Medicament for treating mastopathy | |
| CN100446796C (en) | Externally applied pharmaceutical for bone fracture | |
| CN1197597C (en) | Exterior Chinese medicine Oil-in-Water (O/W) type prescription for reduce swelling and ease pain and its preparing method | |
| CN103285162A (en) | Chinese medicine composition for reinforcing kidney to strengthen yang and preparation method thereof | |
| CN1927286A (en) | Chinese medicine composition for treating skin disease | |
| CN103223022B (en) | Medicine for treating fracture | |
| CN103127287A (en) | Traditional Chinese medicine composition for curing eczema | |
| CN114796325A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method and application thereof | |
| CN100348239C (en) | Traditional Chinese medicine preparation for treating soft tissue pain and preparation method | |
| CN115607611B (en) | A traditional Chinese medicine composition for external treatment of unabrupted superficial lymph node tuberculosis | |
| CN110327387A (en) | The Chinese medicinal plaster and preparation method thereof for treating tinnitus | |
| CN110420305B (en) | Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof | |
| CN101607069B (en) | Chinese traditional medicine for treating phlebitis, old lower extremity venous ulcer and venous purpura disease | |
| CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
| CN104971209A (en) | Externally used agent for treating tinea pedis and preparation method thereof | |
| CN1559502A (en) | Chinese medicinal composition for treating sexual dysfunction | |
| CN103263636B (en) | Traditional Chinese medicine for fracture healing and preparation method thereof | |
| CN1742816A (en) | Wujiaofeng root external-use medicine | |
| CN101439110B (en) | Chinese medicine for curing rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081001 Termination date: 20120612 |